NeoVirTech SAS opens a new laboratory at the Cancerology Research Center of Toulouse (CRCT)
NeoVirTech SAS opens a new laboratory at the Cancerology Research Center of Toulouse (CRCT) Pierre Cordelier équipe ImPact : Therapeutic innovation in pancreatic cancer and two members of Neovirtech, Franck Gallardo (CEO) and Elie marcheteau NeoVirTech SAS opens a new...
Presentation of the CREFRE UMS006 Inserm phenotyping service
#CRCTSCHOLARThe CRCTconferences Presentation of the CREFRE UMS006 Inserm phenotyping service Conference by Sophie Le Gonidec, Research Engineer, on Friday 15 October 2021 as part of the Comité d’Animation Scientifique -CAS Within the Regional Centre for...
Impact of co-administration of two amino acid solutions on the elimination and adverse effects of 177Lu-Dotatate
Impact of co-administration of two amino acid solutions on the elimination and adverse effects of 177Lu-Dotatate 177Lu-Dotatate Somatostatin analogs population pharmacokinetic analysis relationship pharmacokinetic/pharmacodynamics neuroendocrin tumor theranostic...